SCHEMBL3835657

SCHEMBL3835657

NC(=O)Oc1[nH]c2ccccc2c1Sc1ccccn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
PKM P14618 2/20 0.43
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
TUBB4A P04350 4/20 0.37
TUBB P07437 4/20 0.37
TUBA3C P0DPH7 4/20 0.37
TUBA1B P68363 4/20 0.37
TUBA4A P68366 4/20 0.37
TUBB4B P68371 4/20 0.37
TUBB3 Q13509 4/20 0.37
TUBB2A Q13885 4/20 0.37
TUBB8 Q3ZCM7 4/20 0.37
TUBA3E Q6PEY2 4/20 0.37
TUBA1A Q71U36 4/20 0.37
TUBA1C Q9BQE3 4/20 0.37
TUBB6 Q9BUF5 4/20 0.37
TUBB2B Q9BVA1 4/20 0.37
TUBB1 Q9H4B7 4/20 0.37
ICAM1 P05362 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4039379 0.89 CHUK (0.42) ALDH1A1PKMPTGS1PTGS2ICAM1
SCHEMBL4033284 0.86 PTGS1 (0.37) ALDH1A1PKMPTGS1PTGS2ICAM1
SCHEMBL3837588 0.84 ALDH1A1 (0.43) ALDH1A1PKMPTGS1PTGS2TUBB4A
SCHEMBL3268887 0.81 PTGS1 (0.35) ALDH1A1PKMPTGS1PTGS2ICAM1
SCHEMBL3272415 0.81 ICAM1 (0.36) ALDH1A1PKMPTGS1PTGS2ICAM1
SCHEMBL2347705 0.81 MAP2 (0.47) ALDH1A1PKMPTGS1PTGS2TUBB4A
SCHEMBL3835279 0.80 TUBB4A (0.56) ALDH1A1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL3274125 0.79 ICAM1 (0.34) ALDH1A1PKMPTGS1PTGS2ICAM1
SCHEMBL3837185 0.77 GFER (0.43) ALDH1A1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4038757 0.74 MAP2 (0.46) ALDH1A1TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1791537-B1 3-ARYLTHIOINDOLE-2-CARBOXAMIDE DERIVATIVES AND ANALOGS THEREOF AS INHIBITORS OF CASEIN KINASE I AVENTIS PHARMA INC (US) 2009-10-14 EP claimed